General MedicationsINJECTIONGeneric
LEVOPROME
LEVOMEPROMAZINE
Standard Dose
20MG/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview LEVOPROME is listed in Drugs@FDA under application 015865 (NDA).
Marketing status: Discontinued Active ingredient LEVOMEPROMAZINE Form and strength INJECTABLE;INJECTION - 20MG/ML Sponsor IMMUNEX Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview LEVOPROME is listed in Drugs@FDA under application 015865 (NDA). Marketing status: Discontinued Active ingredient LEVOMEPROMAZINE Form and strength INJECTABLE;INJECTION - 20MG/ML Sponsor IMMUNEX Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.